Organon (OGN) Invested Capital (2020 - 2026)

Organon has reported Invested Capital for 7 years, with the latest figure at $74.0 million in Q2 2026.

• Invested Capital for Q2 2026 came in at $74.0 million, down 35.65% year-over-year; the trailing twelve-month figure through Jun 2026 was $151.0 million (down 8.48% YoY), and the FY2025 annual result was $16.0 million, down 20.0% from the prior year.
• Invested Capital grew to $74.0 million in Q2 2026, from $16.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $115.0 million in Q2 2025 and troughed at $8.0 million in Q3 2022.
• A 5-year average of $22.3 million and a median of $9.0 million in 2022 frame the typical range for Invested Capital.
• The widest annual swing landed in 2022, when Invested Capital plunged 99.41%; it then jumped 1177.78% in 2025.
• A 5-year view of Invested Capital shows it stood at $8.0 million in 2022, then increased by 12.5% to $9.0 million in 2023, then soared by 122.22% to $20.0 million in 2024, then slipped by 20.0% to $16.0 million in 2025, then soared by 362.5% to $74.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $74.0 million in Q2 2026, $16.0 million in Q1 2026, and $16.0 million in Q4 2025.